Autism does not make substance use problems inevitable, and it does not rule them out. Research on people with both autism spectrum disorder and substance use disorder needs careful interpretation because studies have examined different populations, used different definitions, and often involved small or highly selected groups. For autistic adults and loved ones in Georgia, the most useful conclusion is not a single risk percentage. It is the importance of understanding the individual without treating a diagnosis as a prediction.
A systematic review published August 17, 2016, offers an account of those evidence gaps. Its findings describe research available at that time, not a complete assessment of everything published since then.
Does autism mean someone will develop a substance problem?
No. An autism diagnosis alone does not establish whether a particular adult has substance-related problems. The distinction matters when considering an individualized addiction treatment plan, which connects care to personal circumstances rather than assumptions. Adults exploring general outpatient options can contact River City Recovery without interpreting its general services as an autism-specialty program.
The National Institute of Mental Health autism overview, last reviewed in December 2024 and accessed November 6, 2026, describes autism as a neurological and developmental disorder affecting interaction, communication, learning, and behavior. It also emphasizes the wide range of symptoms, accompanying health conditions, and service needs among autistic people. That diversity is important: sharing an autism diagnosis does not mean sharing the same daily experiences or support needs.
Substance use and substance use disorder also should not be treated as interchangeable research outcomes. Someone reporting any alcohol use, someone describing trouble associated with drinking, and someone meeting diagnostic criteria for a disorder do not necessarily belong in the same category. The 2016 systematic review of autism and co-occurring substance use disorder identified substantial differences in how the included studies defined substance problems.
Two opposite assumptions therefore go beyond the evidence: that autistic people are protected from substance problems, or that autism necessarily leads to them. The review documented co-occurrence but could not establish a general prevalence rate. Its findings cannot determine an individual adult's situation from a diagnosis alone.
Respectful interpretation leaves room for both possibilities. An autistic adult may have no substance-related concerns, or may have concerns deserving attention. Neither situation should be dismissed because it conflicts with a stereotype about autism.
Why can the prevalence estimates not be combined into one rate?
The studies did not consistently count the same outcomes in comparable populations. A percentage from one selected setting cannot automatically represent autistic adults across Georgia. The same distinction between group labels and individual needs underlies personalized addiction care planning; a conversation about outpatient care concerns the person seeking help, not a percentage borrowed from another population.
The review included 18 papers, with its literature search updated in January 2016. The evidence included adolescents and adults, clinical samples, register-based research, and highly selected forensic populations. Only one included study examined autism prevalence within a substance use disorder population. Asking how often substance problems occur among autistic people is different from asking how often autism occurs among people receiving substance-related care.
The studies also differed in age, intellectual functioning, sex distribution, and definitions of substance problems. Some used formal diagnoses; others used broader reports of alcohol or drug difficulties. The following examples, summarized in the review, show why the underlying population and measurement matter even before considering a percentage.
| Study and country | Population and setting | Substance-related measure | Interpretation limit |
|---|---|---|---|
| Abdallah and colleagues, 2011, Denmark | 414 autism cases from a national register of people born between 1982 and 2004 | Diagnosed alcohol-related disorders using ICD-8 classification | A register diagnosis is not equivalent to all substance use or all unrecorded problems. |
| Lundström and colleagues, 2011, Sweden | Two nationwide twin cohorts examining autistic-like traits | A single yes-or-no item about lifetime alcohol or drug problems | Autistic-like traits and a broad lifetime question are not equivalent to diagnosed autism and current SUD. |
| Helverschou and colleagues, 2015, Norway | 48 people with autism examined by forensic psychiatric experts during 2000–2010 | Reports of substance use, dependency, and intoxication related to charges | Selection through forensic assessment prevents generalization to the wider autistic population. |
These are examples of study design, not estimates of risk for a Georgia adult. A forensic sample, in particular, reflects selection through a legal and assessment setting. It cannot establish that autism causes criminal behavior or describe autistic people generally.
The review's authors concluded that differences between samples made an overall co-occurrence rate difficult to establish. Combining unlike definitions would create a deceptively simple number. Keeping the population, setting, timeframe, and outcome attached to each finding is more informative than averaging results that answer different questions.
What did participants report about their reasons for using substances?
Some participants described using substances to manage distress or social difficulties, but these accounts do not establish a universal explanation. Understanding a person's own experience fits the broader purpose of an individualized treatment plan. Someone seeking general care information can speak with River City Recovery admissions, without assuming that any research participant's reasons apply to them.
The review summarized a 2014 qualitative study involving 12 adult patients with both autism and substance use disorder. The review's study summary does not specify the recruitment country or a precise clinical setting for that sample. Participants' reported reasons for using alcohol or illegal drugs included the following:
- Forgetting problems or clearing their minds.
- Acting more socially or attaining peace of mind.
- Getting through the day.
- Getting over frustration.
These findings describe what a small group said substances did for them. They do not show how frequently those motivations occur among autistic adults, whether the same explanations apply across countries, or whether autism itself caused the substance use. Qualitative accounts can reveal experiences worth understanding without estimating how common those experiences are.
The same study summary reported both perceived short-term relief and negative longer-term consequences. Participants described substance use as disrupting daily life, while lack of structure could contribute to further use. The review characterized that relationship as a cycle. This is not evidence that substances are an effective or safe way to address autism-related needs.
The distinction between a person's reason for using and a demonstrated benefit matters. A report that alcohol made social situations feel easier explains an experience; it does not establish improved social functioning over time. Likewise, a report of temporary relief cannot answer questions about longer-term harms or appropriate treatment.
For loved ones, the practical implication is to avoid substituting a research explanation for the adult's own account. The findings support curiosity about individual experience, not a presumption that every autistic person uses substances for anxiety, social connection, or the same combination of reasons.
What did the review establish about autism-adapted treatment?
It did not establish the effectiveness of a specific autism-adapted substance use treatment. Personalization, as described in individualized addiction treatment planning, is different from proof that a particular adaptation works. The River City Recovery contact page can clarify general outpatient options, but it does not establish a validated autism-specific treatment service.
The 2016 review found no studies testing specified treatment interventions for co-occurring autism and substance use disorder. That is a finding about the literature included in that review, whose search was updated in January 2016. It should not be rewritten as a claim that no relevant research has appeared since then. Equally, the review cannot support a present-day promise that a particular adapted method has been proven effective.
The review did include Netherlands research involving 31 patients with both diagnoses recruited from mental health and addiction treatment services. Related papers published in 2015 described care needs, coping, and personal recovery. Those reports offered information about people's experiences and needs, but did not test a specified intervention.
This distinction separates several kinds of evidence. A description of unmet needs may explain why services require attention. A report of preferred communication may suggest an approach worth evaluating. Neither, by itself, demonstrates that a treatment improves substance-related outcomes. Treatment effectiveness requires evidence about the treatment and its results, not only a plausible rationale.
The review also discussed potential difficulties with some group-based treatment demands. Those concerns should not become a blanket conclusion that all autistic adults cannot benefit from groups. NIMH's description of varied service needs reinforces the importance of avoiding an identical expectation for everyone. A concern about fit and a finding about effectiveness remain separate questions.
How can adults and loved ones use this evidence respectfully?
Use the research to recognize uncertainty while keeping the adult's actual concerns central. An individualized addiction treatment plan connects services to health, goals, substance patterns, and daily circumstances. Adults considering routine outpatient care can contact River City Recovery in Columbus, GA to discuss available options without assuming that autism alone determines the appropriate care.
A person-centered discussion does not require the adult or family to settle the research questions first. It also does not require treating every difficulty as a consequence of autism. The NIMH overview identifies a broad range of accompanying physical and mental health conditions and differing service needs. The substance use review likewise emphasizes the complexity of co-occurring concerns, rather than a single explanation for every person.
Several boundaries help keep the evidence useful:
- Keep the person's reported experience separate from assumptions based on a diagnostic label.
- Distinguish any substance use, reported problems, and a formally assessed disorder.
- Do not apply a selected study sample's findings as an individual prediction.
- Separate a proposed accommodation or preference from evidence that a treatment improves outcomes.
Family involvement also should not replace the adult's perspective. The individualized-care framework recognizes personal goals and preferences alongside health needs. Research can help relatives understand why simple assumptions are unreliable, but it cannot decide the person's goals, diagnose a disorder, or determine an appropriate treatment arrangement from a distance.
River City Recovery provides adult outpatient addiction and mental health care based in Columbus, GA. Admissions can explain general outpatient options and how assessment informs consideration of care. This general service information does not establish autism-specific expertise, availability of a particular adaptation, admission eligibility, or a treatment outcome. Its contact form asks people not to include sensitive health details.
Routine education and admissions conversations are not emergency services. The NIMH overview advises calling or texting 988 for suicidal thoughts or a mental health crisis. In a life-threatening situation, call 911. Immediate safety needs should not wait for an ordinary outpatient inquiry.
Frequently asked questions
Does autism make substance use disorder inevitable?
No. Autism does not establish whether an individual has or will develop substance use disorder. The 2016 review documented co-occurrence but could not establish a general prevalence rate because studies differed substantially. An adult's actual substance use, experiences, and health concerns matter more than assumptions that autism either guarantees substance problems or prevents them.
Why do estimates of substance problems in autistic people vary?
Studies examined different ages, settings, diagnostic groups, and definitions of substance problems. Some measured diagnosed disorders; others recorded broader lifetime difficulties or substance use. Selected clinical and forensic populations also differ from community populations. The 2016 review therefore cautioned against treating its heterogeneous findings as one general rate applicable to all autistic people.
What reasons for substance use did participants report?
A qualitative study summarized in the review included 12 adults with autism and substance use disorder. Participants described forgetting problems, clearing their minds, acting more socially, finding peace of mind, getting through the day, and overcoming frustration. These small-sample accounts describe perceived reasons, not universal motivations or proof that substances safely or effectively address those needs.
Are autism-adapted SUD treatments proven to work?
The 2016 review cannot establish that. It found no studies testing specified interventions for people with both autism and substance use disorder, although it discussed needs and possible clinical approaches. That finding applies to the literature it included, with searches updated in January 2016. It does not settle what later research has found or validate a particular adaptation.

